Medicine preparation for treating colorectal cancer and purpose thereof

Abstract

The invention provides a medicine preparation for treating colorectal cancer and a purpose thereof, and belongs to the field of medicine. The medicine preparation is prepared from the following ingredients in parts by weight: 20 to 30 parts of herba patriniae, 20 to 30 parts of bittersweet herb, 9 to 15 parts of radix astragali seu hedysari, 10 to 20 parts of spatholobus stems, 10 to 20 parts of rhizoma polygonati, 8 to 15 parts of rhizoma corydalis, 5 to 15 parts of trogopterus dung, 10 to 20 parts of hairyvein agrimony, 10 to 20 parts of herba portulacae, 10 to 20 parts of poria cocos, 5 to 10 parts of rhizoma cyperi, 5 to 10 parts of radix linderae, 3 to 9 parts of liquorice roots, 6 to 15 parts of fructus aurantii, 10 to 20 parts of rhizoma polygoni cuspidate, 10 to 20 parts of herba scutellariae barbatae and 10 to 20 parts of radix stephaniae tetrandrae. The traditional Chinese medicine preparation has the advantages that the formula is scientific and rigorous; the medicine preparation is suitable for colorectal cancer patients in various age periods. The clinical treatment process discovers that the medicine preparation has low side effect and can be combined to be used with various chemotherapy medicine or radiation treatment; the tumor focus is reduced; the life cycle of a tumor patient is prolonged; the discomfortableness of the tumor patient due to chemotherapy or operation is reduced; the life quality of the patient is improved.

Description

technical field [0001] The invention belongs to the field of medicine, and in particular relates to a pharmaceutical preparation for treating colorectal cancer and its application. Background technique [0002] Colorectal cancer (CRC) is one of the common malignant tumors, including colon cancer and rectal cancer, which seriously threatens human health. The incidence of colorectal cancer ranks third among malignant tumors. There are about 1 million new cases worldwide each year, and at least 500,000 patients die at the same time. According to statistics, in 2008, there were 1.2 million new cases worldwide, of which at least 600,000 patients died, and the incidence rate of men was much higher than that of women. And with the improvement of living standards and changes in dietary structure, the incidence of colorectal cancer continues to rise. Surgical treatment is the first choice for the treatment of colorectal cancer, and the 5-year survival rate is only about 50%. At p...

AI Technical Summary

Problems solved by technology

At present, due to the low early diagnosis rate and high recurrence and metastasis rate of colorectal cancer, in addition to surgical treatment, comprehensive drug therapy for colorectal cancer has been paid more and more attention